Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients

Romanos Sklavenitis-Pistofidis; Marzia Capelletti; Chia Jen Liu; Mairead Reidy; Oksana Zavidij; Daisy Huynh; Patrick Henrick; Alexandra Savell; Kaitlen Reyes; Bradley Rivotto; Mark Bustoros; Adriana Perilla-Glen; Lorenzo Trippa; Jorge J. Castillo; Steven P. Treon; Irene M. Ghobrial

doi:10.1182/blood-2018-07-863241

Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients

Romanos Sklavenitis-Pistofidis, Marzia Capelletti, Chia Jen Liu, Mairead Reidy, Oksana Zavidij, Daisy Huynh, Patrick Henrick, Alexandra Savell, Kaitlen Reyes, Bradley Rivotto, Mark Bustoros, Adriana Perilla-Glen, Lorenzo Trippa, Jorge J. Castillo, Steven P. Treon, Irene M. Ghobrial^*

^*此作品的通信作者

急重症醫學研究所

研究成果: Letter › 同行評審

30 引文斯高帕斯（Scopus）

原文	English
頁（從 - 到）	2608-2612
頁數	5
期刊	Blood
卷	132
發行號	24
DOIs	https://doi.org/10.1182/blood-2018-07-863241
出版狀態	Published - 13 12月 2018

存取文件

10.1182/blood-2018-07-863241

其它文件與鏈接

Link to publication in Scopus

引用此

Sklavenitis-Pistofidis, R., Capelletti, M., Liu, C. J., Reidy, M., Zavidij, O., Huynh, D., Henrick, P., Savell, A., Reyes, K., Rivotto, B., Bustoros, M., Perilla-Glen, A., Trippa, L., Castillo, J. J., Treon, S. P., & Ghobrial, I. M. (2018). Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients. Blood, 132(24), 2608-2612. https://doi.org/10.1182/blood-2018-07-863241

@article{4791f9d1694240e985222b377a675530,

title = "Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients",

author = "Romanos Sklavenitis-Pistofidis and Marzia Capelletti and Liu, {Chia Jen} and Mairead Reidy and Oksana Zavidij and Daisy Huynh and Patrick Henrick and Alexandra Savell and Kaitlen Reyes and Bradley Rivotto and Mark Bustoros and Adriana Perilla-Glen and Lorenzo Trippa and Castillo, {Jorge J.} and Treon, {Steven P.} and Ghobrial, {Irene M.}",

note = "Funding Information: This work was supported in part by the National Cancer Institute, National Institutes of Health (grant R01 CA205954), the Leukemia and Lymphoma Society, and the International Waldenstr{\"o}m Macroglobulinemia Foundation. I.M.G. is a Scholar in Clinical Research of the Leukemia & Lymphoma Society. The authors acknowledge the generous support of the Michele & Stephen Kirsch Fund for Waldenstr{\"o}m Macroglobulinemia (I.M.G.).",

year = "2018",

month = dec,

day = "13",

doi = "10.1182/blood-2018-07-863241",

language = "English",

volume = "132",

pages = "2608--2612",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "24",

}

Sklavenitis-Pistofidis, R, Capelletti, M, Liu, CJ, Reidy, M, Zavidij, O, Huynh, D, Henrick, P, Savell, A, Reyes, K, Rivotto, B, Bustoros, M, Perilla-Glen, A, Trippa, L, Castillo, JJ, Treon, SP & Ghobrial, IM 2018, 'Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients', Blood, 卷 132, 編號 24, 頁 2608-2612. https://doi.org/10.1182/blood-2018-07-863241

TY - JOUR

T1 - Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients

AU - Sklavenitis-Pistofidis, Romanos

AU - Capelletti, Marzia

AU - Liu, Chia Jen

AU - Reidy, Mairead

AU - Zavidij, Oksana

AU - Huynh, Daisy

AU - Henrick, Patrick

AU - Savell, Alexandra

AU - Reyes, Kaitlen

AU - Rivotto, Bradley

AU - Bustoros, Mark

AU - Perilla-Glen, Adriana

AU - Trippa, Lorenzo

AU - Castillo, Jorge J.

AU - Treon, Steven P.

AU - Ghobrial, Irene M.

N1 - Funding Information: This work was supported in part by the National Cancer Institute, National Institutes of Health (grant R01 CA205954), the Leukemia and Lymphoma Society, and the International Waldenström Macroglobulinemia Foundation. I.M.G. is a Scholar in Clinical Research of the Leukemia & Lymphoma Society. The authors acknowledge the generous support of the Michele & Stephen Kirsch Fund for Waldenström Macroglobulinemia (I.M.G.).

PY - 2018/12/13

Y1 - 2018/12/13

UR - http://www.scopus.com/inward/record.url?scp=85058494001&partnerID=8YFLogxK

U2 - 10.1182/blood-2018-07-863241

DO - 10.1182/blood-2018-07-863241

M3 - Letter

C2 - 30366921

AN - SCOPUS:85058494001

SN - 0006-4971

VL - 132

SP - 2608

EP - 2612

JO - Blood

JF - Blood

IS - 24

ER -